Pliant Therapeutics Correlations

PLRX Stock

USD 13.53 0.19 1.42%

The current 90-days correlation between Pliant Therapeutics and Bright Minds Biosciences is 0.08 (i.e., Significant diversification). The correlation of Pliant Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Pliant Therapeutics Correlation With Market

Very weak diversification

The correlation between Pliant Therapeutics and DJI is 0.44 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pliant Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Pliant Stock please use our How to Invest in Pliant Therapeutics guide.

Moving together with Pliant Stock

0.72	PHVS	Pharvaris BV	Pair Corr
0.7	PMVP	Pmv Pharmaceuticals	Pair Corr
0.61	CRVS	Corvus Pharmaceuticals	Pair Corr

Moving against Pliant Stock

0.47	MNOV	MediciNova	Pair Corr
0.44	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.37	FDMT	4D Molecular Therapeutics	Pair Corr
0.31	NKTX	Nkarta Inc Buyout Trend	Pair Corr
0.31	PEPG	PepGen	Pair Corr
0.65	ACIU	AC Immune	Pair Corr
0.45	SYBX	Synlogic	Pair Corr
0.35	COLL	Collegium Pharmaceutical	Pair Corr
0.34	BDTX	Black Diamond Therap	Pair Corr
0.32	ANEB	Anebulo Pharmaceuticals	Pair Corr

Related Correlations Analysis

	DRUG	HPQ	INTC	CVX	KO	TRV	JNJ	JPM	MSFT
DRUG		0.63	0.56	0.64	-0.8	0.81	-0.55	0.72	0.01	DRUG
HPQ	0.63		0.81	0.81	-0.64	0.65	-0.66	0.75	0.03	HPQ
INTC	0.56	0.81		0.81	-0.69	0.62	-0.81	0.65	0.22	INTC
CVX	0.64	0.81	0.81		-0.84	0.7	-0.86	0.87	-0.08	CVX
KO	-0.8	-0.64	-0.69	-0.84		-0.74	0.88	-0.86	0.09	KO
TRV	0.81	0.65	0.62	0.7	-0.74		-0.56	0.75	0.18	TRV
JNJ	-0.55	-0.66	-0.81	-0.86	0.88	-0.56		-0.75	0.04	JNJ
JPM	0.72	0.75	0.65	0.87	-0.86	0.75	-0.75		-0.13	JPM
MSFT	0.01	0.03	0.22	-0.08	0.09	0.18	0.04	-0.13		MSFT
	DRUG	HPQ	INTC	CVX	KO	TRV	JNJ	JPM	MSFT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

JNJ	+ 0.88	KO
JPM	+ 0.87	CVX
TRV	+ 0.81	DRUG
INTC	+ 0.81	HPQ
CVX	+ 0.81	HPQ
CVX	+ 0.81	INTC

High negative correlations

JPM	- 0.86	KO
JNJ	- 0.86	CVX
KO	- 0.84	CVX
JNJ	- 0.81	INTC
KO	- 0.8	DRUG
JPM	- 0.75	JNJ

Risk-Adjusted Indicators

There is a big difference between Pliant Stock performing well and Pliant Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pliant Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
DRUG	49.12	28.18	2.88	(0.77)	4.62	(58.09)	9.23	(11.87)	1,471
HPQ	1.31	0.03	0.02	0.15	1.62	(1.30)	2.22	(2.63)	6.13
INTC	2.36	0.04	0.07	0.14	2.58	(2.68)	6.36	(3.50)	18.29
CVX	0.90	0.07	0.02	0.22	1.05	(0.93)	2.21	(1.79)	5.13
KO	0.68	(0.15)	0.00	(1.28)	0.00	0.00	1.11	(1.66)	4.00
TRV	1.08	0.15	0.11	0.27	1.17	(1.26)	1.93	(2.17)	11.31
JNJ	0.61	(0.10)	0.00	(0.37)	0.00	0.00	1.40	(1.42)	3.25
JPM	1.12	(0.01)	0.06	0.12	1.42	(1.19)	2.05	(2.00)	15.87
MSFT	0.90	(0.03)	(0.04)	0.07	1.49	(0.86)	2.09	(1.85)	8.19

Pliant Therapeutics Corporate Management

Hal MD	Scientific Board	Profile
Mike Ouimette	Gen Sec	Profile
Rik Derynck	Scientific Board	Profile
Dean MD	Scientific Board	Profile
Johannes Hull	Chief Officer	Profile
MBA MD	CEO Pres	Profile
Christopher Keenan	Vice Communications	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC